BioMark Diagnostics Inc.
OTC: BMKDF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rashid Ahmed Maula Bux
- Employees
- 9
- Headquarters
- Richmond, Canada
- IPO year
- 2015
- Market cap
- $41.2M
- Website
- https://www.biomarkdiagnostics.com
Loading BMKDF…
Loading profile data…Frequently asked questions about BMKDF
What does BioMark Diagnostics Inc. (BMKDF) do?
BioMark Diagnostics Inc. is an oncology-focused firm that develops sophisticated diagnostic tools for cancer. These solutions are designed to aid in the identification of the disease, its ongoing monitoring, and the assessment of initial therapeutic interventions. The company has a research partnership with the Icahn School of Medicine, under wh...
Where does BMKDF trade?
BioMark Diagnostics Inc. (BMKDF) trades on the Other OTC.
What sector is BMKDF in?
BioMark Diagnostics Inc. (BMKDF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BioMark Diagnostics Inc.?
Rashid Ahmed Maula Bux is the chief executive officer of BioMark Diagnostics Inc. (BMKDF).
Where is BioMark Diagnostics Inc. headquartered?
BioMark Diagnostics Inc. is headquartered in Canada.
Does BMKDF pay a dividend?
BioMark Diagnostics Inc. (BMKDF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BMKDF go public?
BioMark Diagnostics Inc. (BMKDF) completed its initial public offering in 2015.